ANTIBODY CO-FORMULATION TOOLBOX AND CAPABILITIES ESTABLISHED IN WUXI BIOLOGICS

INTRODUCTION: Co-formulation containing two or more antibodies (mAbs) is deemed to hold distinct merits such as better treatment efficacy, higher efficiency and extended intellectual property right, attracting the demands from both patients and pharmaceutical companies. However, there are only limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Anyuan, Weng, Jingwen, Zhou, Fangyuan, Wang, Kewei, Wu, Hongbing, Wang, Shawn, Guo, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370435/
http://dx.doi.org/10.1093/abt/tbad014.018

Ejemplares similares

Ejemplares similares